414
Participants
Start Date
June 30, 2002
Primary Completion Date
October 31, 2007
Study Completion Date
December 31, 2007
Sodium Stibogluconate (SSG)
100 mg/ml/vial. Treatment for laboratory-confirmed leishmaniasis with SSG 20mg/kg/d intravenously (IV) for 10 days or 20 days for less responsive; visceral leishmaniasis will be treated with SSG 20mg/kg/d IV for 28 days as a second line of therapy for those failing or intolerant of Ambisome; and mucosal leishmaniasis will be treated with SSG 20mg/kg/d IV for 28 days.
Walter Reed Army Medical Center, Washington D.C.
Walter Reed Army Medical Center
FED
U.S. Army Medical Research and Development Command
FED